Sign in
PTLF Stock Price, Chart, Stats & News
Petlife Pharmaceuticals, Inc.
Save
Petlife Pharmaceuticals, Inc. (PTLF) does not currently pay a dividend.
19,675
Market cap
0.01x
Current P/E
–
Forward P/E
PTLF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Based in Los Angeles, California, Petlife Pharmaceuticals, Inc. is dedicated to the discovery, formulation, commercialization, and ongoing support of both medicinal drugs and nutritional supplements for pets. Their primary focus is on addressing canine and feline cancer and various autoimmune conditions, such as arthritis, within the United States market. The company's leading product is Vitalzul, which functions by obstructing the formation of new blood vessels crucial for the growth of solid tumors.
Similar securities
Based on sector and market capitalization
Report issue